Novel cytostatic 7-deazapurine nucleosides
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F19%3A00520268" target="_blank" >RIV/61388963:_____/19:00520268 - isvavai.cz</a>
Result on the web
<a href="https://esearch.ipd.gov.hk/nis-pos-view/pt#/details/1910325_17108215.3/0/1/10/0/null_null/KCFeIShwdWJsaWNOdW1iZXI6KDEyMzQ0MTEpKSFeISkgQU5EIHB0UmVjb3JkU2VxOjE=" target="_blank" >https://esearch.ipd.gov.hk/nis-pos-view/pt#/details/1910325_17108215.3/0/1/10/0/null_null/KCFeIShwdWJsaWNOdW1iZXI6KDEyMzQ0MTEpKSFeISkgQU5EIHB0UmVjb3JkU2VxOjE=</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Novel cytostatic 7-deazapurine nucleosides
Original language description
The invention provides compounds of formula I, wherein R 1 and R 2 have any of the values defined in the specification and salts thereof, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
HK1234411
Publisher
CN002 -
Publisher name
Patent Office - State Intellectual Property Office of the Peoples` Republic of China (SIPO)
Place of publication
Beijing
Publication country
CN - CHINA
Date of acceptance
Jun 6, 2019
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence